Implications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort

Author:

Wendel Garcia Pedro D., ,Aguirre-Bermeo Hernán,Buehler Philipp K.,Alfaro-Farias Mario,Yuen Bernd,David Sascha,Tschoellitsch Thomas,Wengenmayer Tobias,Korsos Anita,Fogagnolo Alberto,Kleger Gian-Reto,Wu Maddalena A.,Colombo Riccardo,Turrini Fabrizio,Potalivo Antonella,Rezoagli Emanuele,Rodríguez-García Raquel,Castro Pedro,Lander-Azcona Arantxa,Martín-Delgado Maria C.,Lozano-Gómez Herminia,Ensner Rolf,Michot Marc P.,Gehring Nadine,Schott Peter,Siegemund Martin,Merki Lukas,Wiegand Jan,Jeitziner Marie M.,Laube Marcus,Salomon Petra,Hillgaertner Frank,Dullenkopf Alexander,Ksouri Hatem,Cereghetti Sara,Grazioli Serge,Bürkle Christian,Marrel Julien,Fleisch Isabelle,Perez Marie-Helene,Baltussen Weber Anja,Ceruti Samuele,Marquardt Katharina,Hübner Tobias,Redecker Hermann,Studhalter Michael,Stephan Michael,Selz Daniela,Pietsch Urs,Ristic Anette,Heise Antje,Meyer zu Bentrup Friederike,Franchitti Laurent Marilene,Fodor Patricia,Gaspert Tomislav,Haberthuer Christoph,Colak Elif,Heuberger Dorothea M.,Fumeaux Thierry,Montomoli Jonathan,Guerci Philippe,Schuepbach Reto A.,Hilty Matthias P.,Roche-Campo FerranORCID

Abstract

Abstract Background Uncertainty about the optimal respiratory support strategies in critically ill COVID-19 patients is widespread. While the risks and benefits of noninvasive techniques versus early invasive mechanical ventilation (IMV) are intensely debated, actual evidence is lacking. We sought to assess the risks and benefits of different respiratory support strategies, employed in intensive care units during the first months of the COVID-19 pandemic on intubation and intensive care unit (ICU) mortality rates. Methods Subanalysis of a prospective, multinational registry of critically ill COVID-19 patients. Patients were subclassified into standard oxygen therapy ≥10 L/min (SOT), high-flow oxygen therapy (HFNC), noninvasive positive-pressure ventilation (NIV), and early IMV, according to the respiratory support strategy employed at the day of admission to ICU. Propensity score matching was performed to ensure comparability between groups. Results Initially, 1421 patients were assessed for possible study inclusion. Of these, 351 patients (85 SOT, 87 HFNC, 87 NIV, and 92 IMV) remained eligible for full analysis after propensity score matching. 55% of patients initially receiving noninvasive respiratory support required IMV. The intubation rate was lower in patients initially ventilated with HFNC and NIV compared to those who received SOT (SOT: 64%, HFNC: 52%, NIV: 49%, p = 0.025). Compared to the other respiratory support strategies, NIV was associated with a higher overall ICU mortality (SOT: 18%, HFNC: 20%, NIV: 37%, IMV: 25%, p = 0.016). Conclusion In this cohort of critically ill patients with COVID-19, a trial of HFNC appeared to be the most balanced initial respiratory support strategy, given the reduced intubation rate and comparable ICU mortality rate. Nonetheless, considering the uncertainty and stress associated with the COVID-19 pandemic, SOT and early IMV represented safe initial respiratory support strategies. The presented findings, in agreement with classic ARDS literature, suggest that NIV should be avoided whenever possible due to the elevated ICU mortality risk.

Funder

CytoSorbents Europe GmbH

Union Bancaire Privée

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3